Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2017-10-10 to 2017-10-13
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
other: OECD Guideline for the Testing of Chemicals No. 439: In Vitro Skin Irritation: Reconstructed human Epidermis Test Method, 28 July 2015
Deviations:
no
Qualifier:
according to guideline
Guideline:
other: Commission Regulation (EC) No. 640/2012, L 193, Part B.46. “In vitro Skin Irritation: Reconstructed Human Epidermis Test Method” 06-Jul-2012
Deviations:
no
Qualifier:
according to guideline
Guideline:
other: L’Oréal Standard Operating Procedure: “EpiSkin™ Skin Irritation Test Method“; - ECVAM Skin Irritation Validation Study - Validation of the EpiSkin™ Test Method15 min - 42 hours for the Prediction of Acute Skin Irritation of Chemicals.
Version / remarks:
Version 1.8, Feb-2009
Deviations:
no
Qualifier:
according to guideline
Guideline:
other: ECVAM DB-ALM Protocol No. 131 “EpiSkin™ Skin Irritation Test15 min – 42 hours. 09-Jun-2012
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, München, Germany

Test material

Constituent 1
Chemical structure
Reference substance name:
diethyl({3-[(4-nitrophenyl)formamido]propyl})azanium chloride
EC Number:
814-319-5
Cas Number:
110393-28-7
Molecular formula:
C14H22N3O3Cl
IUPAC Name:
diethyl({3-[(4-nitrophenyl)formamido]propyl})azanium chloride
Test material form:
solid: particulate/powder

In vitro test system

Test system:
human skin model
Vehicle:
water
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
1. Negative control 10 µL Dulbecco's phosphate buffered saline
2. Positive control 10 µL 5% sodium dodecyl sulfate solution
3. Test Item 10 ± 2 mg + 10 µL aqua dest.
Duration of treatment / exposure:
15 min
Duration of post-treatment incubation (if applicable):
42 ± 1 h
Number of replicates:
The test was performed on a total of 3 tissues per dose group.

Test system

Details on study design:
The test was performed on EpiSkin, an organotypic reconstructed three-dimensional model of the human epidermis. 3 replicate tissues are dosed with the test item, the negative control (10µL DPBS) and the positive control (10µL 5% SDS), respectively. After 15 minutes treatment period at room temperature the test item and the controls are rinsed off with DPBS and the tissues are post-incubated for 42 +/- 1 h. Then the tissues are stained via MTT for 3 hours. Isopropanol extracts are measured photometrically at 570 nm.

Results and discussion

In vitro

Resultsopen allclose all
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
1
Value:
118.3
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
valid
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
2
Value:
116.6
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
valid
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
3
Value:
116.6
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
valid
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
mean
Value:
117.2
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
valid

Any other information on results incl. tables

Result of the Test Item N-[3-(Diethylamino)propyl]-4-nitrobenzamide, hydrochloride

 

Name

Negative Control

Positive Control

Test Item

Tissue

1

2

3

1

2

3

1

2

3

Absolute OD570

1.003

0.958

0.999

0.111

0.097

0.109

1.165

1.146

1.142

0.997

0.956

1.031

0.110

0.097

0.094

1.164

1.151

1.155

OD570(Blank-Corrected)

0.961

0.916

0.956

0.069

0.054

0.066

1.123

1.103

1.100

0.955

0.914

0.989

0.068

0.055

0.052

1.122

1.108

1.113

Mean OD570Of The Duplicates (Blank-Corrected)

0.958

0.915

0.973

0.068

0.055

0.059

1.122

1.106

1.106

 Total Mean OD570Of 3 Replicate Tissues (Blank-Corrected)

0.949*

0.061

1.112

SD OD570

0.030

0.007

0.009

Relative Tissue Viabilities [%]

101.0

96.5

102.5

7.2

5.8

6.2

118.3

116.6

116.6

Mean Relative Tissue Viability [%]

100.0

6.4**

117.2

SD Tissue Viability [%]***

3.2

0.7

1.0

CV [% Viability]

3.2

11.4

0.8

 

*               Corrected mean OD570of the negative control corresponds to 100% absolute tissue viability.

**             Mean relative tissue viability of the three positive control tissues is  40%.

***            Standard deviation (SD) obtained from the three concurrently tested tissues is  18%.

Applicant's summary and conclusion

Interpretation of results:
other: non-irritant
Conclusions:
In this study under the given conditions the test item showed no irritant effects. The relative mean tissue viability after 15 min of exposure and 42 h post-incubation was > 50%. The test item is therefore classified as “non-irritant” in accordance with UN GHS “No Category”.
Executive summary:

In the present study theskin irritant potential of N-[3-(Diethylamino)propyl]-4-nitrobenzamide, hydrochloride was analysed. The EPISKIN-Standard Model™ (EPISKIN-SMTM), a reconstituted three-dimensional human epidermis model, was used as a replacement for the Draize Skin Irritation Test (OECD TG 404[8]) to distinguish between UN GHS “Category 2” skin irritating test substances and not categorized test substances (“No Category”) which may be considered as non-irritant. Hereby, the test item was applied topically. Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from MTT after a 15 min exposure and 42 h post-incubation period and compared to those of the concurrent negative controls.The test item showed no irritant effects. The mean relative tissue viability (% negative control) was > 50% (117.2%) after 15 min treatment and 42 h post-incubation